Shenzhen Weiguang Biological Products Co., Ltd. - Laporan Laba Rugi (TTM)

Shenzhen Weiguang Biological Products Co., Ltd.
CN ˙ SZSE
CN¥ 28.10 ↑0.30 (1.08%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Shenzhen Weiguang Biological Products Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 895 905 854 833 914 907 907 803 702 668 739 893 992 1,049 1,066 1,114 1,167 1,203 1,202 1,198
Change (%) 1.06 -5.62 -2.45 9.71 -0.68 -0.10 -11.37 -12.62 -4.87 10.59 20.93 11.05 5.70 1.70 4.50 4.75 3.09 -0.11 -0.29
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 552 568 521 508 551 537 533 465 414 427 470 563 603 615 622 655 693 699 703 689
Change (%) 2.94 -8.30 -2.58 8.63 -2.71 -0.64 -12.74 -10.92 3.04 10.04 19.81 7.19 1.96 1.12 5.30 5.76 0.93 0.59 -2.10
% of Revenue 61.67 62.82 61.03 60.95 60.36 59.13 58.80 57.90 59.02 63.93 63.61 63.02 60.83 58.68 58.35 58.79 59.36 58.12 58.53 57.47
Gross Operating Profit 343 336 333 325 362 371 373 338 288 241 269 330 389 433 444 459 474 504 498 510
Change (%) -1.98 -1.09 -2.25 11.39 2.41 0.69 -9.42 -14.96 -16.26 11.57 22.89 17.62 11.52 2.52 3.38 3.31 6.23 -1.08 2.26
% of Revenue 38.33 37.18 38.97 39.05 39.64 40.87 41.20 42.10 40.98 36.07 36.39 36.98 39.17 41.32 41.65 41.21 40.64 41.88 41.47 42.53
SG&A 91 80 83 80 89 90 89 88 83 90 91 104 109 124 131 129 132 126 125 137
Change (%) -11.79 4.07 -3.75 10.80 0.59 -0.36 -1.94 -5.29 8.99 0.50 14.95 4.30 14.34 4.90 -1.46 2.24 -4.27 -0.98 9.51
% of Revenue 10.16 8.87 9.78 9.65 9.75 9.87 9.84 10.89 11.80 13.52 12.29 11.68 10.97 11.87 12.24 11.54 11.27 10.46 10.37 11.39
R&D 46 45 49 47 51 48 49 42 41 36 36 40 58 64 65 66 51 49 48 50
Change (%) -2.45 8.50 -3.91 8.68 -6.87 1.99 -13.61 -1.71 -12.97 1.00 11.05 44.24 9.63 2.21 1.05 -21.94 -4.36 -1.37 2.88
% of Revenue 5.16 4.99 5.73 5.65 5.59 5.24 5.35 5.22 5.87 5.37 4.90 4.50 5.85 6.07 6.10 5.90 4.39 4.08 4.03 4.15
OpEx 696 700 659 641 697 681 679 601 545 551 595 708 772 807 822 856 885 879 882 878
Change (%) 0.47 -5.77 -2.86 8.88 -2.34 -0.36 -11.40 -9.42 1.27 7.82 19.14 8.93 4.52 1.96 4.05 3.41 -0.62 0.34 -0.50
% of Revenue 77.81 77.36 77.23 76.91 76.33 75.05 74.85 74.83 77.56 82.57 80.50 79.31 77.80 76.93 77.12 76.80 75.82 73.09 73.42 73.27
Operating Income 199 205 194 192 216 226 228 202 158 116 144 185 220 242 244 259 282 324 320 320
Change (%) 3.10 -5.09 -1.06 12.48 4.67 0.70 -11.29 -22.12 -26.08 23.72 28.32 19.15 9.84 0.82 5.99 9.19 14.70 -1.32 0.28
% of Revenue 22.19 22.64 22.77 23.09 23.67 24.95 25.15 25.17 22.44 17.43 19.50 20.69 22.20 23.07 22.88 23.20 24.18 26.91 26.58 26.73
Interest Expense -2 -1 -1 -0 -1 -2 -2 -1 -2 -2 -3 -2 -10 -14 -18 -19 -25 -22 -22 -27
Change (%) -43.66 -10.65 -61.01 63.63 211.19 -10.97 -17.93 31.58 14.16 38.69 -37.27 478.33 38.52 24.95 7.68 30.19 -12.65 0.29 22.51
% of Revenue -0.21 -0.12 -0.11 -0.04 -0.07 -0.21 -0.18 -0.17 -0.26 -0.31 -0.39 -0.20 -1.04 -1.37 -1.68 -1.73 -2.15 -1.82 -1.83 -2.25
Net Income 183 190 186 183 207 205 204 182 141 118 138 172 196 219 220 227 250 254 250 251
Change (%) 4.09 -2.47 -1.53 13.26 -0.80 -0.80 -10.51 -22.94 -16.38 17.36 24.46 14.17 11.56 0.50 3.52 9.94 1.36 -1.21 0.34
% of Revenue 20.43 21.05 21.75 21.96 22.67 22.64 22.48 22.70 20.02 17.59 18.67 19.22 19.76 20.85 20.61 20.42 21.43 21.07 20.84 20.97

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista